✦ LIBER ✦

Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segment elevation acute coronary syndrome patients

✍ Scribed by de Andrade, Pedro; e Mattos, Luiz Alberto; Tebet, Marden; Rinaldi, Fábio; Esteves, Vinícius; Nogueira, Ederlon; França, João Ítalo; de Andrade, Mônica Vieira; Barbosa, Robson; Labrunie, André; Abizaid, Alexandre Antônio; Sousa, Amanda Guerra de Moraes Rego

Book ID: 121584410
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 404 KB
Volume: 14
Category: Article
ISSN: 1468-6708
DOI: 10.1186/1745-6215-14-435

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design and rationale of the RadIal Vs. f

Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes

✍ Sanjit S. Jolly; Kari Niemelä; Denis Xavier; Petr Widimsky; Andrzej Budaj; Vicen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 268 KB

5-Year Clinical Outcomes in the ICTUS (I

5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial: A Randomized Comparison of an Early Invasive Versus Selective Invasive Management in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

✍ Peter Damman; Alexander Hirsch; Fons Windhausen; Jan G.P. Tijssen; Robbert J. de 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 566 KB

The Early Glycoprotein IIb/IIIa Inhibiti

The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale

✍ Robert P. Giugliano; L. Kristin Newby; Robert A. Harrington; C. Michael Gibson; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Design and rationale of the Treatment of

Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy

✍ Philippe Gabriel Steg; Shamir R. Mehta; Charles V. Pollack Jr.; Christoph Bode; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Design and rationale of the MICHELANGELO

Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)–5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non–ST-segment elevation acute coronary syndromes

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 758 KB

Relation of T-Wave Alternans to Mortalit

Relation of T-Wave Alternans to Mortality and Nonsustained Ventricular Tachycardia in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome from the MERLIN-TIMI 36 Trial of Ranolazine Versus Placebo

✍ Nieminen, Tuomo; Scirica, Benjamin M.; Pegler, Jose R.M.; Tavares, Caio; Pagotto 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 440 KB